Trials / Completed
CompletedNCT03140540
TEE as a Guide for Fluid Optimization in Major Abdominal Oncosurgery
Transesophageal Echocardiography as a Guide for Fluid Optimization in Major Abdominal Oncosurgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Rajiv Gandhi Cancer Institute & Research Center, India · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Transesophageal echocardiography (TEE) as guide for tailoring perioperative fluid therapy to achieve individualized hemodynamic endpoint, target hemodynamic goals of stroke volume index (SVI) greater than 35 mL/m2 and cardiac index greater than 2.5 L/min/m2 and tissue oxygen delivery. Lactate levels as a surrogate indicator of organ perfusion as measured by arterial blood gas analysis intraoperatively, after 12 hours and 48 hrs postoperatively
Detailed description
TEE as guide for tailoring perioperative fluid therapy to achieve target hemodynamic goals of stroke volume index (SVI) greater than 35 mL/m2 and cardiac index greater than 2.5 L/min/m2 and tissue oxygen delivery. GDT (goal directed therapy): continuous infusion of crystalloids 2 mL/kg/h. If (velocity time integral) VTI \<20, 250 mL colloid bolus administered. Dose repeated every 10 min until goal of VTI \>20 met. Norepinephrine titrated to maintain MAP(mean arterial pressure) \> 65 mm Hg. Blood transfused for haemoglobin \<8 g Lactate levels as a surrogate indicator of organ perfusion as measured by arterial blood gas analysis at time of incision intraoperatively and after 12 hours and 48 hrs. The incidence of postoperative complications, morbidity, mortality, duration of mechanical ventilation and ICU stay.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | TEE guided fluid therapy will be administered | Transesophageal echocardiography will be used to guide the fluid therapy. Velocity time integral of aorta \<20 ,200ml colloid bolus to be administered. |
| OTHER | Stroke volume variation guided intravenous fluid. | Active Comparator: Group A control group (SVV guided fluid ) Stroke volume variation guided intraoperative intravenous fluid will be administered. SVV \>10, 200 ml of colloid bolus to be given |
Timeline
- Start date
- 2019-02-16
- Primary completion
- 2020-02-27
- Completion
- 2020-02-27
- First posted
- 2017-05-04
- Last updated
- 2020-10-26
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT03140540. Inclusion in this directory is not an endorsement.